Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Sanguine AB
AB
Active
Org 5591014534
Linnégatan 11, 413 04
Göteborg
Restaurant activities
·
NACE 5611
Est. 2017 · 9 years old
0 employees
Monitor
Share
Sweden
/
Companies
/
Restaurant activities
/
Sanguine AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
4M
3M
2M
1M
0M
2020: 2M
2M
2020
2021: 3M (+50% vs 2020)
3M
+50%
2021
2022: 2M (-33% vs 2021)
2M
-33%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 1M
1M
2024
EBITDA
SEK millions
0M
0M
-1M
-1M
-1M
2020: -1M
-1M
2020
2021: 0M (+100% vs 2020)
0M
2021
2022: 0M
0M
2022
2023: -1M
-1M
2023
2024: 0M (+100% vs 2023)
0M
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
874
419
2 172
2 968
1 674
Staff expenses
—
—
—
—
—
EBITDA
−119
−878
−242
−432
−990
Depreciation & amort.
−0
−0
−412
−0
−0
EBIT
−119
−878
−654
−432
−990
Net financials
−37
−1
−22
−6
−13
Profit before tax
−156
−879
−675
−438
−1 003
Tax
−0
−0
−0
−0
−0
Net profit
−156
−879
−675
−438
−1 003
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
456
198
774
3 393
3 408
Equity
−2 994
−2 838
−1 959
−1 284
−846
Long-term debt
2 584
1 856
1 633
3 943
3 709
Short-term debt
867
1 180
1 100
734
544
Total debt
3 451
3 036
2 733
4 677
4 253
Financial ratios
5-year trend
EBITDA margin
-13.6%
This company
15.8%
Market median
This company
Market median
186% below market
2020
2024
Equity ratio
-656.6%
This company
38.2%
Market median
This company
Market median
>999% below market
2020
2024
Return on equity
—
This company
18.4%
Market median
This company
Market median
2020
2024
Net profit margin
-17.8%
This company
8.1%
Market median
This company
Market median
320% below market
2020
2024
Asset turnover
1.92×
This company
1.12×
Market median
This company
Market median
71% above market
2020
2024
Debt / equity
—
This company
0.62×
Market median
This company
Market median
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Sanguine AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
